STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
On 20 November 2013, the Board of Directors of NeuroVive Pharmaceutical AB (publ) (“NeuroVive”) decided to execute a rights issue. Coincident with this new share issue, NeuroVive has published a prospectus today, which has been approved and registered by the Swedish Financial Supervisory Authority.
Help employers find you! Check out all the jobs and post your resume.
